Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases

Молекулярная гибридизация как инструмент разработки мультицелевых лекарственных кандидатов для лечения нейродегенеративных заболеваний
Kris Simone Tranches Dias, Cláudio Viegas, Vanessa Silva Gontijo, Flávia P. Dias Viegas, Cindy Juliet Cristancho Ortiz, Matheus de Freitas Silva, Caio Miranda Damásio, Mayara Chagas Rosa, Thâmara Gaspar Campos, Dyecika Souza Couto
2019-10-21

molecular hybridizationmultifunctional drug candidatesmultitarget-directed ligandsneurodegenerative diseasespolypharmacology
Neurodegenerative Diseases (NDs) are progressive multifactorial neurological pathologies related to neuronal impairment and functional loss from different brain regions. Currently, no effective treatments are available for any NDs, and this lack of efficacy has been attributed to the multitude of interconnected factors involved in their pathophysiology. In the last two decades, a new approach for the rational design of new drug candidates, also called multitarget-directed ligands (MTDLs) strategy, has emerged and has been used in the design and for the development of a variety of hybrid compounds capable to act simultaneously in diverse biological targets. Based on the polypharmacology concept, this new paradigm has been thought as a more secure and effective way for modulating concomitantly two or more biochemical pathways responsible for the onset and progress of NDs, trying to overcome low therapeutical effectiveness. As a complement to our previous review article (Curr. Med. Chem. 2007, 14 (17), 1829-1852. https://doi.org/10.2174/092986707781058805), herein we aimed to cover the period from 2008 to 2019 and highlight the most recent advances of the exploitation of Molecular Hybridization (MH) as a tool in the rational design of innovative multifunctional drug candidate prototypes for the treatment of NDs, specially focused on AD, PD, HD and ALS.
1
Molecular hybridization is presented as a rational strategy for designing multifunctional drug candidates that act on diverse biological targets.
2
Multitarget-directed ligands use polypharmacology to modulate multiple biochemical pathways simultaneously, potentially improving therapeutic effectiveness in neurodegenerative diseases.
3
Neurodegenerative diseases involve interconnected multifactorial mechanisms, contributing to the lack of effective treatments.
4
The approach aims to overcome the limited efficacy of single-target therapies by combining activities relevant to neurodegenerative disease pathophysiology.
5
The review surveys molecular-hybridization advances from 2008 to 2019, focusing on candidate prototypes for Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis.

molecularly hybridized multifunctional drug candidate prototypes for neurodegenerative diseases, especially Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis

the rational design and development of multitarget-directed ligands that concomitantly modulate multiple biochemical pathways and targets involved in the onset and progression of neurodegenerative diseases

Publication Details
Publication Date
2019-10-21
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Kris Simone Tranches Dias
Cláudio Viegas
Vanessa Silva Gontijo
Flávia P. Dias Viegas
Cindy Juliet Cristancho Ortiz
Matheus de Freitas Silva
Caio Miranda Damásio
Mayara Chagas Rosa
Thâmara Gaspar Campos
Dyecika Souza Couto
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%